|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schiller JH, Harrington D, Belani CP,
Langer C, Sandler A, Krook J, Zhu J and Johnson DH: Eastern
Cooperative Oncology Group: Comparison of four chemotherapy
regimens for advanced non-small-cell lung cancer. N Engl J Med.
346:92–98. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pérez-Soler R: Individualized therapy in
non-small-cell lung cancer: future versus current clinical
practice. Oncogene. 28(Suppl 1): S38–S45. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Igney FH and Krammer PH: Death and
anti-death: tumour resistance to apoptosis. Nat Rev Cancer.
2:277–288. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Los M, Burek CJ, Stroh C, Benedyk K, Hug H
and Mackiewicz A: Anticancer drugs of tomorrow: apoptotic pathways
as targets for drug design. Drug Discov Today. 8:67–77. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Reed JC: Apoptosis-based therapies. Nat
Rev Drug Discov. 1:111–121. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liao PC, Chien SC, Ho CL, Wang EI, Lee SC,
Kuo YH, Jeyashoke N, Chen J, Dong WC, Chao LK and Hua KF: Osthole
regulates inflammatory mediator expression through modulating
NF-κB, mitogen-activated protein kinases, protein kinase C, and
reactive oxygen species. J Agric Food Chem. 58:10445–10451. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu JH, Zschocke S, Reininger E and Bauer
R: Inhibitory effects of Angelica pubescens f. biserrata on
5-lipoxygenase and cyclooxygenase. Planta Med. 64:525–529. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matsuda H, Tomohiro N, Ido Y and Kubo M:
Anti-allergic effects of cnidii monnieri fructus (dried fruits of
Cnidium monnieri) and its major component, osthol. Biol Pharm Bull.
25:809–812. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu WB, Zhou J, Qu Y, Li X, Lu CT, Xie KL,
Sun XL and Fei Z: Neuroprotective effect of osthole on MPP+-induced
cytotoxicity in PC12 cells via inhibition of mitochondrial
dysfunction and ROS production. Neurochem Int. 57:206–215. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kuo PL, Hsu YL, Chang CH and Chang JK:
Osthole-mediated cell differentiation through bone morphogenetic
protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway
in human osteoblast cells. J Pharmacol Exp Ther. 314:1290–1299.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang RL, Chen CC, Huang YL, Hsieh DJ, Hu
CP, Chen CF and Chang C: Osthole increases glycosylation of
hepatitis B surface antigen and suppresses the secretion of
hepatitis B virus in vitro. Hepatology. 24:508–515. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang LL, Wang MC, Chen LG and Wang CC:
Cytotoxic activity of coumarins from the fruits of Cnidium monnieri
on leukemia cell lines. Planta Med. 69:1091–1095. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chou SY, Hsu CS, Wang KT, Wang MC and Wang
CC: Antitumor effects of Osthol from Cnidium monnieri: an in vitro
and in vivo study. Phytother Res. 21:226–230. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Riviere C, Goossens L, Pommery N, Fourneau
C, Delelis A and Henichart JP: Antiproliferative effects of
isopentenylated coumarins isolated from Phellolophium
madagascariense Baker. Nat Prod Res. 20:909–916. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deveraux QL and Reed JC: IAP family
proteins - suppressors of apoptosis. Genes Dev. 13:239–252. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
LaCasse EC, Baird S, Korneluk RG and
MacKenzie AE: The inhibitors of apoptosis (IAPs) and their emerging
role in cancer. Oncogene. 17:3247–3259. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Deveraux QL, Takahashi R, Salvesen GS and
Reed JC: X-linked IAP is a direct inhibitor of cell-death
proteases. Nature. 388:300–304. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roy N, Deveraux QL, Takahashi R, Salvesen
GS and Reed JC: The c-IAP-1 and c-IAP-2 proteins are direct
inhibitors of specific caspases. EMBO J. 16:6914–6925. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Salvesen GS and Duckett CS: IAP proteins:
blocking the road to death's door. Nat Rev Mol Cell Biol.
3:401–410. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liston P, Fong WG and Korneluk RG: The
inhibitors of apoptosis: there is more to life than Bcl2. Oncogene.
22:8568–8580. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nachmias B, Ashhab Y and Ben-Yehuda D: The
inhibitor of apoptosis protein family (IAPs): an emerging
therapeutic target in cancer. Semin Cancer Biol. 14:231–243. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tamm I, Kornblau SM, Segall H, Krajewski
S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A, et al:
Expression and prognostic significance of IAP-family genes in human
cancers and myeloid leukemias. Clin Cancer Res. 6:1796–1803.
2000.PubMed/NCBI
|
|
24
|
Bertrand MJ, Milutinovic S, Dickson KM, Ho
WC, Boudreault A, Durkin J, Gillard JW, Jaquith JB, Morris SJ and
Barker PA: cIAP1 and cIAP2 facilitate cancer cell survival by
functioning as E3 ligases that promote RIP1 ubiquitination. Mol
Cell. 30:689–700. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chitra M, Sukumar E, Suja V and Devi CS:
Antitumor, anti-inflammatory and analgesic property of embelin, a
plant product. Chemotherapy. 40:109–113. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nikolovska-Coleska Z, Xu L, Hu Z, Tomita
Y, Li P, Roller PP, Wang R, Fang X, Guo R, Zhang M, et al:
Discovery of embelin as a cell-permeable, small-molecular weight
inhibitor of XIAP through structure-based computational screening
of a traditional herbal medicine three-dimensional structure
database. J Med Chem. 47:2430–2440. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu Y, Cherton-Horvat G, Dragowska V, Baird
S, Korneluk RG, Durkin JP, Mayer LD and LaCasse EC: Antisense
oligonucleotides targeting XIAP induce apoptosis and enhance
chemotherapeutic activity against human lung cancer cells in vitro
and in vivo. Clin Cancer Res. 9:2826–2836. 2003.PubMed/NCBI
|
|
28
|
Asselin E, Mills GB and Tsang BK: XIAP
regulates Akt activity and caspase-3-dependent cleavage during
cisplatin-induced apoptosis in human ovarian epithelial cancer
cells. Cancer Res. 61:1862–1868. 2001.PubMed/NCBI
|
|
29
|
Lu J, Huang Y, Zhao W, Marquez RT, Meng X,
Li J, Gao X, Venkataramanan R, Wang Z and Li S: PEG-derivatized
embelin as a nanomicellar carrier for delivery of paclitaxel to
breast and prostate cancers. Biomaterials. 34:1591–1600. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang D, Gu T, Wang T, Tang Q and Ma C:
Effects of osthole on migration and invasion in breast cancer
cells. Biosci Biotechnol Biochem. 74:1430–1434. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tsai CF, Yeh WL, Chen JH, Lin C, Huang SS
and Lu DY: Osthole suppresses the migratory ability of human
glioblastoma multiforme cells via inhibition of focal adhesion
kinase-mediated matrix metalloproteinase-13 expression. Int J Mol
Sci. 15:3889–3903. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Okamoto T, Kobayashi T and Yoshida S:
Chemical aspects of coumarin compounds for the prevention of
hepatocellular carcinomas. Curr Med Chem Anticancer Agents.
5:47–51. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu XM, Zhang Y, Qu D, Feng XW, Chen Y and
Zhao L: Osthole suppresses migration and invasion of A549 human
lung cancer cells through inhibition of matrix metalloproteinase-2
and matrix metallopeptidase-9 in vitro. Mol Med Rep. 6:1018–1022.
2012.PubMed/NCBI
|
|
34
|
Xu X, Zhang Y, Qu D, Jiang T and Li S:
Osthole induces G2/M arrest and apoptosis in lung cancer A549 cells
by modulating PI3K/Akt pathway. J Exp Clin Cancer Res. 30:332011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu XM, Zhang Y, Qu D, Liu HB, Gu X, Jiao
GY and Zhao L: Combined anticancer activity of osthole and
cisplatin in NCI-H460 lung cancer cells in vitro. Exp Ther Med.
5:707–710. 2013.PubMed/NCBI
|
|
36
|
Duckett CS, Nava VE, Gedrich RW, Clem RJ,
Van Dongen JL, Gilfillan MC, Shiels H, Hardwick JM and Thompson CB:
A conserved family of cellular genes related to the baculovirus iap
gene and encoding apoptosis inhibitors. EMBO J. 15:2685–2694.
1996.PubMed/NCBI
|
|
37
|
Srinivasula SM, Hegde R, Saleh A, Datta P,
Shiozaki E, Chai J, Lee RA, Robbins PD, Fernandes-Alnemri T, Shi Y
and Alnemri ES: A conserved XIAP-interaction motif in caspase-9 and
Smac/DIABLO regulates caspase activity and apoptosis. Nature.
410:112–116. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu Z, Sun C, Olejniczak ET, Meadows RP,
Betz SF, Oost T, Herrmann J, Wu JC and Fesik SW: Structural basis
for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature.
408:1004–1008. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Eckelman BP, Drag M, Snipas SJ and
Salvesen GS: The mechanism of peptide-binding specificity of IAP
BIR domains. Cell Death Differ. 15:920–928. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tenev T, Zachariou A, Wilson R, Ditzel M
and Meier P: IAPs are functionally non-equivalent and regulate
effector caspases through distinct mechanisms. Nat Cell Biol.
7:70–77. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang HK, Joazeiro CA, Bonfoco E, Kamada
S, Leverson JD and Hunter T: The inhibitor of apoptosis, cIAP2,
functions as a ubiquitin-protein ligase and promotes in vitro
monoubiquitination of caspases 3 and 7. J Biol Chem.
275:26661–26664. 2000.PubMed/NCBI
|
|
42
|
Choi YE, Butterworth M, Malladi S, Duckett
CS, Cohen GM and Bratton SB: The E3 ubiquitin ligase cIAP1 binds
and ubiquitinates caspase-3 and −7 via unique mechanisms at
distinct steps in their processing. J Biol Chem. 284:12772–12782.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Samuel T, Okada K, Hyer M, Welsh K, Zapata
JM and Reed JC: cIAP1 localizes to the nuclear compartment and
modulates the cell cycle. Cancer Res. 65:210–218. 2005.PubMed/NCBI
|
|
44
|
Imoto I, Tsuda H, Hirasawa A, Miura M,
Sakamoto M, Hirohashi S and Inazawa J: Expression of cIAP1, a
target for 11q22 amplification, correlates with resistance of
cervical cancers to radiotherapy. Cancer Res. 62:4860–4866.
2002.PubMed/NCBI
|
|
45
|
Tanimoto T, Tsuda H, Imazeki N, Ohno Y,
Imoto I, Inazawa J and Matsubara O: Nuclear expression of cIAP-1,
an apoptosis inhibiting protein, predicts lymph node metastasis and
poor patient prognosis in head and neck squamous cell carcinomas.
Cancer Lett. 224:141–151. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Che X, Yang D, Zong H, Wang J, Li X, Chen
F, Chen X and Song X: Nuclear cIAP1 overexpression is a tumor
stage- and grade-independent predictor of poor prognosis in human
bladder cancer patients. Urol Oncol. 30:450–456. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yang L, Mashima T, Sato S, Mochizuki M,
Sakamoto H, Yamori T, Oh-Hara T and Tsuruo T: Predominant
suppression of apoptosome by inhibitor of apoptosis protein in
non-small cell lung cancer H460 cells: therapeutic effect of a
novel polyarginine-conjugated Smac peptide. Cancer Res. 63:831–837.
2003.PubMed/NCBI
|
|
48
|
Danquah M, Li F, Duke CB III, Miller DD
and Mahato RI: Micellar delivery of bicalutamide and embelin for
treating prostate cancer. Pharm Res. 26:2081–2092. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sreepriya M and Bali G: Chemopreventive
effects of embelin and curcumin against
N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in
Wistar rats. Fitoterapia. 76:549–555. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Dai Y, Qiao L, Chan KW, Yang M, Ye J, Ma
J, Zou B, Gu Q, Wang J, Pang R, et al: Peroxisome
proliferator-activated receptor-gamma contributes to the inhibitory
effects of Embelin on colon carcinogenesis. Cancer Res.
69:4776–4783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Heo JY, Kim HJ, Kim SM, Park KR, Park SY,
Kim SW, Nam D, Jang HJ, Lee SG, Ahn KS, et al: Embelin suppresses
STAT3 signaling, proliferation, and survival of multiple myeloma
via the protein tyrosine phosphatase PTEN. Cancer Lett. 308:71–80.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Avisetti DR, Babu KS and Kalivendi SV:
Activation of p38/JNK pathway is responsible for embelin induced
apoptosis in lung cancer cells: transitional role of reactive
oxygen species. PloS One. 9:e870502014. View Article : Google Scholar : PubMed/NCBI
|
